For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Test Ostomy Barrier | The test product is a new Hollister ostomy barrier. Test Ostomy Barrier | 2 | None | 12 | 79 | 6 | 79 | View |
| Control Ostomy Barrier | The control product is a currently marketed Hollister ostomy barrier. Control Ostomy Barrier | 0 | None | 6 | 74 | 11 | 74 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Myocardial infarction | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Death due to septic shock | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Pelvic Abscess | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Renal Failure | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Intestinal Blockage/Illeus | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Acute shortness of breath | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Urinary Tract Infection | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Death due to primary cancer | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | None | View |
| Abdominal Pain | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Inflamed gall bladder | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Non-specific Failure to Thrive | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Non-specific Pain | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Cellulitis | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Elective colonoscopy | SYSTEMATIC_ASSESSMENT | Surgical and medical procedures | None | View |
| Incisional Abscess | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Intestinal Blockage/Illeus | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Stoma abrasion caused by patient | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| Skin Rash | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Ostomy pouching system not secure | SYSTEMATIC_ASSESSMENT | Product Issues | None | View |
| Peristomal Skin Complication | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Stoma complication | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |